NRP1 and melanoma: In contrast, Gal-1 silencing significantly curbed that NRP1 upregulation observed in PLX-resistant melanoma cells at both the mRNA (Figure 3A,B) and protein levels (Figure 3E,F), thus suggesting a positive loop mediated by autocrine ligand production.